P
Precirix
Biotech & Life Sciences · Jette, Belgium · Founded 2014
Camelid-derived radiopharmaceuticals for targeted cancer therapy MoreLess
Precirix is a pioneering biotechnology company focused on transforming the field of cancer treatment through innovative solutions. Established with the aim of addressing significant challenges in oncology, Precirix is dedicated to developing advanced diagnostic and therapeutic tools that enhance the precision and effectiveness of cancer care.
The company's flagship technology centers on its proprietary radio-labeled imaging agents, which are designed to improve the accuracy of cancer detection and treatment planning. By leveraging cutting-edge radiopharmaceuticals and advanced imaging techniques, Precirix aims to provide clinicians with more precise diagnostic information, leading to better-informed treatment decisions and improved patient outcomes.
In addition to its diagnostic capabilities, Precirix is also at the forefront of developing targeted therapies that combine imaging and treatment in a single approach. This integrated strategy allows for more personalized and effective treatment options, tailored to the specific characteristics of each patient’s cancer.
Precise and timely cancer treatment is crucial for improving survival rates and quality of life. Precirix’s innovative approach promises to enhance the overall efficacy of cancer management by offering solutions that address both the diagnostic and therapeutic needs of oncology.
With a commitment to advancing cancer care through technology, Precirix is poised to make significant contributions to the field, ultimately aiming to improve patient outcomes and revolutionize the approach to cancer treatment.
Company overview
Precirix company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2014
- Headquarters
- Jette, Belgium
- Employees
- 10
- Open positions
- None listed
- Dealroom signal
- 61.4
Valuation & funding
Precirix funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Mar 2022 | $88M | $352M | BioMedVC · HealthCap · Pontifax Funds · Inkef | ↗ |
| SERIES AOther financing | Nov 2018 | $42M | $168M | HealthCap · Novo Seeds · Gimv · BioMedVC | — |
| SPINOUTOther financing | Jan 2014 | $0 | — | Vrije Universiteit Brussel | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | EBITDA | Margin |
|---|---|---|
| 2026 | −$5.2M | — |
| 2025 | −$5.2M | — |
| 2024 | −$5.2M | — |
| 2023 | −$5.2M | — |
| 2022 | −$5.2M | — |
| 2021 | −$1.4M | — |
| 2020 | −$584K | — |
Growth signals
Precirix website traffic
Latest recorded traffic for Precirix is 40 monthly website visits, down 98.1% over the last three months. Precirix's team declined 72.2% over the past year.
Comparisons
Precirix compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Precirix's talent
Source: Dealroom Talent Intelligence.
Investors
11 investors on Precirix's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Precirix has talent and traffic
team presence
In the news
Latest news about Precirix
Recent press, funding announcements, and product moves mentioning Precirix — open to read from the original sources.
Market sentiment
What the market is saying about Precirix
An AI-synthesized read of the highest-engagement posts about Precirix on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Precirix’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.